ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.7939
-0.74%
Brent Oil
83.95
0.47%
Bitcoin
63,086.16
3.10%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sema4 Holdings Corporation (SMFR)

  7. Sema4 Holdings Corporation (SMFR) Noticias

SMFR

Sema4 (SMFR)

Sema4 Holdings Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SMFR
FechaHoraFuenteTítuloSímboloCompañía
21/06/202315:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMFRSema4 Holdings Corporation
20/06/202316:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMFRSema4 Holdings Corporation
09/06/202315:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SMFRSema4 Holdings Corporation
25/04/202316:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SMFRSema4 Holdings Corporation
20/04/202315:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMFRSema4 Holdings Corporation
10/02/202315:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMFRSema4 Holdings Corporation
01/02/202316:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SMFRSema4 Holdings Corporation
30/01/202316:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SMFRSema4 Holdings Corporation
09/01/202307:30GlobeNewswire Inc.Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 GuidanceNASDAQ:SMFRSema4 Holdings Corporation
30/12/202207:30GlobeNewswire Inc.Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:SMFRSema4 Holdings Corporation
05/12/202207:00GlobeNewswire Inc.New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICUNASDAQ:SMFRSema4 Holdings Corporation
14/11/202207:02GlobeNewswire Inc.Sema4 Reports Third Quarter 2022 Financial Results and New Strategic DirectionNASDAQ:SMFRSema4 Holdings Corporation
04/11/202215:05GlobeNewswire Inc.Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022NASDAQ:SMFRSema4 Holdings Corporation
04/11/202204:45PR Newswire (US)SMFR SHAREHOLDER ALERT: Jakubowitz Law Reminds Sema4 Holdings Corp. Shareholders of a Lead Plaintiff Deadline of November 7, 2022NASDAQ:SMFRSema4 Holdings Corporation
02/11/202221:50PR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Sema4 Holdings Corp. - SMFRNASDAQ:SMFRSema4 Holdings Corporation
02/11/202204:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Sema4 Holdings, Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2022 - (NASDAQ: SMFR)NASDAQ:SMFRSema4 Holdings Corporation
31/10/202208:00GlobeNewswire Inc.Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained EpilepsiesNASDAQ:SMFRSema4 Holdings Corporation
27/10/202207:00GlobeNewswire Inc.Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill NewbornsNASDAQ:SMFRSema4 Holdings Corporation
26/10/202207:00GlobeNewswire Inc.Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panelsNASDAQ:SMFRSema4 Holdings Corporation
13/10/202207:00GlobeNewswire Inc.Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum DisordersNASDAQ:SMFRSema4 Holdings Corporation
05/10/202207:00GlobeNewswire Inc.Sema4|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening StudyNASDAQ:SMFRSema4 Holdings Corporation
08/09/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMFRSema4 Holdings Corporation
07/09/202216:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SMFRSema4 Holdings Corporation
26/08/202215:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SMFRSema4 Holdings Corporation
26/08/202207:00GlobeNewswire Inc.Sema4 Appoints Healthcare and Diagnostics Industry Veteran Kevin Feeley as Chief Financial OfficerNASDAQ:SMFRSema4 Holdings Corporation
17/08/202222:25TipRanksBTIG Sticks to Their Buy Rating for Sema4 Holdings (SMFR)NASDAQ:SMFRSema4 Holdings Corporation
15/08/202215:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMFRSema4 Holdings Corporation
15/08/202215:05GlobeNewswire Inc.Sema4 Announces Continued Restructuring, Business Highlights, and Reports Second Quarter 2022 Financial ResultsNASDAQ:SMFRSema4 Holdings Corporation
15/08/202215:05GlobeNewswire Inc.Sema4 Announces Changes to its Research & Development LeadershipNASDAQ:SMFRSema4 Holdings Corporation
26/07/202207:00GlobeNewswire Inc.Sema4 to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022NASDAQ:SMFRSema4 Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:SMFR

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
CCOM
SILVER
SILVER
FX
EURUSD
Euro vs US Dollar
NYSE
BAC
Bank of America
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
NASDAQ
TSLA
Tesla
USI
USTECH100
US Tech 100
FX
USDMXN
US Dollar vs MXN
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
CCOM
OILBRENT
Brent Oil
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados